EcoDrugPlus

Neurotensin Receptor 1

Ensembl ID : ENSCHAG00000014125
Gene Symbol: NTSR1
3 Cross references
133 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCHAG00000024697
Gene Symbol: NTRK2
1 Cross references
210 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSCHAG00000003845
Gene Symbol: NTRK3
1 Cross references
198 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSCHAG00000002438
Gene Symbol: NTRK1
1 Cross references
200 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSCHAG00000023947
Gene Symbol: NTRK2B
1 Cross references
213 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSCHAG00000026474
Gene Symbol: NFE2L2A
1 Cross references
216 Possible Orthologues:

Nicastrin

Ensembl ID : ENSCHAG00000021666
Gene Symbol: NCSTN
1 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSCHAG00000008180
Gene Symbol: NAMPT
1 Cross references
219 Possible Orthologues:

Nischarin

Ensembl ID : ENSCHAG00000021242
Gene Symbol: NISCH
1 Cross references
210 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSCHAG00000025326
Gene Symbol: NOS2
1 Cross references
167 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSCHAG00000024906
Gene Symbol: NOS2
3 Cross references
167 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSCHAG00000021929
Gene Symbol: NOTCH1
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).